Personalised medicine is often described as the future of healthcare. But for patients with cancer and brain disorders, the future is not an abstract concept – it is a question of time, access and the right treatment today. It is precisely at this point that P4Health positions itself – an ambitious initiative to establish a Centre of Excellence for Precise Phenotyping and BioDataBanking in Wrocław, Poland.

P4Health is not just another research project. It is a structural investment in the way biomedical data are collected, connected and used – so that genetic information, clinical observations and lifestyle data can be transformed into real therapeutic solutions.

A Direct Impact on Patients and Healthcare Systems

At the core of P4Health lies a simple but powerful idea: in order to help the patient, we must understand the disease in its specific, individual form. This means creating a detailed biomedical profile – a process referred to as “precise phenotyping”. Within the framework of the project, this includes combining genetic, clinical and behavioural data, integrated through AI-based solutions for working with large volumes of information.

Today, modern medicine can combine genetic signals, clinical indicators and lifestyle data in ways that were unthinkable a decade ago. Nevertheless, in many parts of Central and Eastern Europe, there is a lack of connected infrastructure capable of turning these data into better day-to-day medical care. Limited networking and unevenly developed research ecosystems slow down access to advanced technologies.

P4Health aims precisely to bridge this gap. The project unites biobanking, advanced diagnostics and AI-based data integration into a single working framework. This means that collected biological samples will not merely be stored, but will be actively used to validate therapeutic strategies in cancer and brain disorders.

For society, this translates into several concrete effects:

• better targeted therapies;
• earlier diagnosis;
• improved understanding of individual risk;
• more efficient use of healthcare resources.

The project also has a broader social ambition: to become an expert centre for regulatory bodies that supports interdisciplinary networks, streamlines the functioning of the healthcare system and mobilises the public sector towards more active participation in research.

In this sense, P4Health is building not merely a laboratory, but an infrastructure of trust between patients, scientists, clinicians and institutions.

Strengthening Europe’s Scientific Capacity

P4Health is conceived as a Centre of Excellence based on the already existing research institution Łukasiewicz-PORT in Wrocław. The project does not start from scratch – it builds upon a solid scientific foundation and connects it with leading international expertise.

The key scientific innovation lies in integrating existing resources into a unified, coherent operational system: from participatory biobanking, through advanced diagnostics, to comprehensive validation of therapeutic strategies. This creates an environment in which data are not collected fragmentarily, but are transformed into a continuous flow of information – from the laboratory to the clinic.

At a structural level, the project aims to trigger profound change in the Polish research and innovation sector, making it more modern and more competitive. Through partnerships with leading institutions in France and the United Kingdom, expertise is transferred in the fields of preclinical and clinical research.

This collaboration has a dual effect:

1. It enhances the quality of research infrastructure in Poland.
2. It reduces asymmetries between “widening” countries and traditional scientific leaders within the EU.

The scientific value of P4Health also lies in placing biobanking at the centre of personalised medicine. The biobank is not merely a storage facility for samples, but an active instrument for generating new data, hypotheses and therapeutic solutions.

When AI-based tools integrate large volumes of biomedical information, they create opportunities for identifying new disease patterns and treatment responses. This transforms the centre into a data engine – a key resource for contemporary biomedicine.

Governance, Partnerships and Investment

P4Health is part of the Horizon Europe programme, within the so-called Widening strand, which aims to strengthen the scientific competitiveness of Central and Eastern European countries.

The project receives €15 million in funding from the European Union. The initiative is coordinated by the research institution Łukasiewicz-PORT in Wrocław, Poland. It works in close partnership with CERBM (France) – providing expertise in preclinical research and King’s College London (United Kingdom) – contributing leading experience in clinical research.

The project runs from 1 November 2024 until 31 October 2030 – a six-year horizon that allows not only the construction of infrastructure, but also the sustainable development of capacity.

The funding does not cover laboratory equipment alone. It invests in:

• the establishment of new research teams;
• the creation of integrated workflows;
• networks connecting scientists, clinicians, the pharmaceutical industry and healthcare users;
• increasing the volume of commercialised intellectual property;
• the creation of new business partnerships.

In this sense, the €15 million is not simply a budget, but a strategic instrument for structural transformation.

A Blueprint for the Widening Countries

P4Health has the ambition to serve as a model for other countries in Central and Eastern Europe. The Widening programme is not a temporary compensation mechanism, but a tool for levelling scientific potential across the European Union.

If the project succeeds, it will shorten the distance between cutting-edge biomedical science and clinical reality in the region. For patients, this means a greater chance of receiving interventions tailored not to statistical averages, but to individual biological profiles.

P4Health is building the backbone of personalised medicine where it most urgently requires infrastructure. And if today we speak of it as a Centre of Excellence, tomorrow it may well be recognised as the necessary bridge between data and life.

Autor: Radoslav Todorov

Sources

• https://p4health.eu/
• https://cordis.europa.eu/project/id/101136375
• https://cordis.europa.eu/project/id/101006386/results

Map: SciTransfer.EU (https://map.scitransfer.eu/project/p4health-101136375)